Canada Pharmaceuticals

LSL Pharma Group Inc (LSL)

Track

Over the past 90 days, LSL Pharma Group Inc. recorded three insider buy transactions totaling 52,700 CAD. These purchases were executed by two insiders, including one executive. Despite a 3.8% decline in stock price over the same period, there have been no reported insider sales, following the company's most recent results financiers in May 2026.
Ticker: LSL Exchange: CVE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for LSL Pharma Group Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.6
Paradis, Mario Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
140.97
Quantity 34,351 +14.7%
Value CA$3,870,812
Allard, Guy Paul Senior Officer of Issuer Officer
Transaction date
Purchase
Price
408.22
Quantity 58,781 +38.5%
Value CA$4,575,073
Allard, Guy Paul Senior Officer of Issuer Officer
Transaction date
Purchase
Price
127.69
Quantity 9,884
Value CA$74,334
1.0
Roberge, François 10% Security Holder of Issuer, Director of Issuer, Senior Officer of Issuer Executive Director Large shareholder
Transaction date
Purchase
Price
0.40
Quantity 187,500 +3.9%
Value CA$75,000
1.6
Paradis, Mario Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.40
Quantity 125,000
Value CA$50,000
3.1
Pierre B., Lafrenière Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.38
Quantity 5,500 +28.2%
Value CA$2,062
3.1
Pierre B., Lafrenière Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.39
Quantity 8,000 +69.6%
Value CA$3,080
3.1
Pierre B., Lafrenière Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.38
Quantity 2,000 +21.1%
Value CA$750
3.1
Pierre B., Lafrenière Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.39
Quantity 2,000 +26.7%
Value CA$770
3.1
Pierre B., Lafrenière Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.38
Quantity 3,000 +66.7%
Value CA$1,125
3.1
Pierre B., Lafrenière Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.38
Quantity 4,500
Value CA$1,688
1.6
Paradis, Mario Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.40
Quantity 250,000
Value CA$100,000
3.2
Dellafera, Frank J. Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.40
Quantity 1,250,000 +2916.7%
Value CA$500,000
3.0
Grimard, Jacques 10% Security Holder of Issuer Large shareholder
Transaction date
Purchase
Price
0.40
Quantity 4,692,500 +136.7%
Value CA$1,877,000
3.1
Mainville, Luc Senior Officer of Issuer Officer
Transaction date
Purchase
Price
0.40
Quantity 875,000
Value CA$350,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-19 2026-06-19 B Purchase
1.6
Paradis, Mario

Director of Issuer

Non-Executive Director
34,351 +14.7%
140.97
CA$3,870,812 		34,351 +14.7% 140.97 CA$3,870,812
2026-06-18 2026-06-18 B Purchase
Allard, Guy Paul

Senior Officer of Issuer

Officer
58,781 +38.5%
408.22
CA$4,575,073 		58,781 +38.5% 408.22 CA$4,575,073
2026-06-16 2026-06-15 B Purchase
Allard, Guy Paul

Senior Officer of Issuer

Officer
9,884
127.69
CA$74,334 		9,884 127.69 CA$74,334
2025-09-02 2025-08-29 B Purchase
1.0
Roberge, François

10% Security Holder of Issuer, Director of Issuer, Senior Officer of Issuer

Executive Director Large shareholder
187,500 +3.9%
0.40
CA$75,000 		187,500 +3.9% 0.40 CA$75,000
2025-09-02 2025-08-29 B Purchase
1.6
Paradis, Mario

Director of Issuer

Non-Executive Director
125,000
0.40
CA$50,000 		125,000 0.40 CA$50,000
2025-05-30 2025-05-30 B Purchase
3.1
Pierre B., Lafrenière

Director of Issuer

Non-Executive Director
5,500 +28.2%
0.38
CA$2,062 		5,500 +28.2% 0.38 CA$2,062
2025-05-30 2025-05-30 B Purchase
3.1
Pierre B., Lafrenière

Director of Issuer

Non-Executive Director
8,000 +69.6%
0.39
CA$3,080 		8,000 +69.6% 0.39 CA$3,080
2025-05-30 2025-05-29 B Purchase
3.1
Pierre B., Lafrenière

Director of Issuer

Non-Executive Director
2,000 +21.1%
0.38
CA$750 		2,000 +21.1% 0.38 CA$750
2025-05-30 2025-05-27 B Purchase
3.1
Pierre B., Lafrenière

Director of Issuer

Non-Executive Director
2,000 +26.7%
0.39
CA$770 		2,000 +26.7% 0.39 CA$770
2025-05-30 2025-05-27 B Purchase
3.1
Pierre B., Lafrenière

Director of Issuer

Non-Executive Director
3,000 +66.7%
0.38
CA$1,125 		3,000 +66.7% 0.38 CA$1,125
2025-05-30 2025-05-27 B Purchase
3.1
Pierre B., Lafrenière

Director of Issuer

Non-Executive Director
4,500
0.38
CA$1,688 		4,500 0.38 CA$1,688
2024-06-28 2024-06-26 B Purchase
1.6
Paradis, Mario

Director of Issuer

Non-Executive Director
250,000
0.40
CA$100,000 		250,000 0.40 CA$100,000
2024-04-26 2024-04-23 B Purchase
3.2
Dellafera, Frank J.

Director of Issuer

Non-Executive Director
1,250,000 +2916.7%
0.40
CA$500,000 		1,250,000 +2916.7% 0.40 CA$500,000
2024-03-26 2024-03-18 B Purchase
3.0
Grimard, Jacques

10% Security Holder of Issuer

Large shareholder
4,692,500 +136.7%
0.40
CA$1,877,000 		4,692,500 +136.7% 0.40 CA$1,877,000
2024-03-19 2024-03-18 B Purchase
3.1
Mainville, Luc

Senior Officer of Issuer

Officer
875,000
0.40
CA$350,000 		875,000 0.40 CA$350,000
Explore more

More insider trading research around LSL Pharma Group Inc

More insider trades in Canada
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America